| Dr Charles Whitney Bodreau, PHARMD | |
|
20233 Sw Jay St, Aloha, OR 97003-8137 | |
| (971) 221-8200 | |
| Not Available |
| Full Name | Dr Charles Whitney Bodreau |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 20233 Sw Jay St, Aloha, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255949285 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Charles Whitney Bodreau, PHARMD 20233 Sw Jay St, Aloha, OR 97003-8137 Ph: (971) 221-8200 | Dr Charles Whitney Bodreau, PHARMD 20233 Sw Jay St, Aloha, OR 97003-8137 Ph: (971) 221-8200 |
News Archive
A study by Jeffrey P. Brosco, M.D., Ph.D., of the University of Miami, Florida, and colleagues examines the relationship between medical interventions in early childhood and the increasing prevalence of later intellectual disability.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that the company is advancing its lead program, NU1618, into phase 2b development for the treatment of chronic hyperuricemia in patients with gout. Nuon anticipates releasing topline data from a completed proof-of-principle, phase 2a study of NU1618 in the second quarter of 2010.
A new diagnostic tool that shortens the diagnosis of multidrug-resistant tuberculosis (MDR-TB) from eight weeks to two hours should be made available to vulnerable populations according to a WHO expert, Reuters reports.
Cognitive function may be a better indicator of the impact of aging on an economy than age-distribution, with chronological age imposing less of a social and economic burden if the population is "functionally" younger, according to a study published today in the Proceedings of the National Academy of Sciences.
Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 15mg and 30 mg delayed release capsules of Lansoprazole, which is used in treatment of peptic ulcers. Lansoprazole is the generic name for the brand Prevacid, marketed in the United States by Takeda. Wockhardt is launching the product immediately.
› Verified 2 days ago
Franklin Phan, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3535 Sw 173rd Ave, Aloha, OR 97006 Phone: 503-803-3353 | |
Robert Louie, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15901 Sw Jenkins Rd, Aloha, OR 97006 Phone: 503-626-5754 Fax: 503-626-1187 | |
Kimberly Majors, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17495 Sw Farmington Rd, Aloha, OR 97007 Phone: 503-848-7700 Fax: 503-848-7810 | |
Ms. Trang Thi Dao, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 17495 Sw Farmington Rd, Aloha, OR 97007 Phone: 503-848-7700 Fax: 503-848-7810 | |
Dr. David H Uth, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1764 Sw Harvey Way, Aloha, OR 97006 Phone: 503-704-6970 | |
Mr. Greg Stokesbury, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5975 Sw 185th Ave, Aloha, OR 97007 Phone: 503-649-6562 |